>
Tucker Exposes Trump Would-Be Assassin Thomas Crooks' Social Media History, The FBI Coverup...
This Was A Major Red Flag In 2008, And Now It Is Happening Again!
Trump orders DOJ probe into Epstein's alleged ties with JPMorgan, Clinton and other Democrats
Blue Origin New Glenn 2 Next Launch and How Many Launches in 2026 and 2027
China's thorium reactor aims to fuse power and parity
Ancient way to create penicillin, a medicine from ancient era
Goodbye, Cavities? Scientists Just Found a Way to Regrow Tooth Enamel
Scientists Say They've Figured Out How to Transcribe Your Thoughts From an MRI Scan
SanDisk stuffed 1 TB of storage into the smallest Type-C thumb drive ever
Calling Dr. Grok. Can AI Do Better than Your Primary Physician?
HUGE 32kWh LiFePO4 DIY Battery w/ 628Ah Cells! 90 Minute Build
What Has Bitcoin Become 17 Years After Satoshi Nakamoto Published The Whitepaper?

MIT Technology Review reports that the first use of CRISPR in humans, to edit immune cells, has been proposed by scientists at the University of Pennsylvania. The National Institutes of Health's Recombinant DNA Advisory Committee will meet next week to review the the use of the technology.
The NIH writes in a blog post that the technique would be used to edit two genes in human T cells, which would target myeloma, melanoma, and sarcoma tumor cells.
This comes after an earlier proposal from Editas, a biotech company that plans to use CRISPR to treat eye disorders in 2017.